1 / 19

Evalulation of Azelaic Acid for Non-Prescription Use

Evalulation of Azelaic Acid for Non-Prescription Use. Michelle Brown Andy Reynolds Ted Williams Pharm. D candidates, OSU College of Pharmacy. Search Strategy. Relied primarily on MedLine search Used tertiary resources at the discretions of the author One dermatologist interview. Diseases.

polly
Télécharger la présentation

Evalulation of Azelaic Acid for Non-Prescription Use

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Evalulation of Azelaic Acid for Non-Prescription Use Michelle Brown Andy Reynolds Ted Williams Pharm. D candidates, OSU College of Pharmacy

  2. Search Strategy • Relied primarily on MedLine search • Used tertiary resources at the discretions of the author • One dermatologist interview

  3. Diseases • Mild to Moderate Acne Vulgaris • Rosacea • Melasma

  4. Disease State Definition • Acne • chronic inflammatory disease of the pilosebaceous units in the dermis • Pilosebaceous unit location • Mainly face, back and chest • Also neck and upper arms

  5. Disease State Causes • Causes of Acne • Exact causes unknown • 4 factors involved • Excessive Sebum produced • Hyperkeratinization of the hair follicle • Prevents shedding of the follicular keratinocytes • Leads to the formation of microscopic lesions microcomedo • Accumulation of lipids and cellular debris • Colonization by Propionibacterium acnes

  6. Disease State Progression • Normal Follicle

  7. Disease State Progression • Microcomedo

  8. Disease State Progression • Open Comedo • “Blackhead”

  9. Disease State Progression • Closed Comedo • “Whitehead”

  10. Disease State Progression • Papule • Enflamed lesion

  11. Disease State Progression • Pustule • Enlarged papule • Pus filled • Raised • Reddened

  12. Disease State Progression • Nodule (or Cyst) • Inflammation penetrates deeper into skin • May lead to scarring or pitting

  13. Disease State Classification • Defined by American Academy of Dermatology • Mild Acne • A few to several papules or pustules • Moderate Acne • Several to many papules and pustules along with several nodules • Severe Acne • Numerous or extensive papules and pustules as well as many nodules

  14. Drug Information • Drug Requested • Pharmacology • Dose • Indications • Pharmacokinetics • Side Effects

  15. Efficacy • Demonstrated effective vs. no treatment • Demonstrated effective vs. other topicals (benzoyl peroxide) • Demonstrated effective vs. oral treatments (tetracycline) • Effective in combinations with other topicals (Glycolic Acid) and oral treatments (minocycline)

  16. Safety • Low systemic absorption • FDA Pregnancy category B • Not passed in lactation in above baseline levels • Good option for pregnant patients vs. oral treatments • No known drug interactions

  17. Cost

  18. Conclusions • Effective • Safe • No known Interactions • Low Pregnancy Risk • Elevated Cost vs. Benzoyl Peroxide • Recommended for OTC Use

  19. References • Facts and Comparisons 4.0 Available from URL:Online http://online.factsandcomparisons.com/ • Goulden, V. Guidelines for the Management of Acne Vulgaris in Adolescents. Pediatric Drugs 2003;5(5):301-313 • Feldman, S, Careccia R, Barham K, Hancox J. Diagnosis and Treatment of Acne.. American Family Physician 2004;69:2123-30 • Thiboutot D. New Treatments and Therapeutic Strategies for Acne Treatment. Archives of Family Medicine 2000;9:179-187. Berardi R, McDermott J, Newton G, Oszko M, Popovich N, Rollims C, et al. Handbook of Nonprescription Drugs 2004;913-927. • The Red Book, (2003). • Arash Akhaven and Susan Bershad, “Topical Acne Drugs; Review of Clinical Properties, Systemic Exposure, and Safety,” Am J Clin Dermatol 2003, 4(7): 473-492. • Mackrides, P S, Shaughnessy A F, “Azelaic Acid Therapy for Acne,” American Family Physician 1996, 54(8): 2457-2459. • Spellman M.C. and Pincus, S.H., “Efficacy and Safety of Azelaic Acid and Glycolic Acid Combination Therapy Compared with Tretinoin Therapy for Acne,” Clinical Therapeutics 1998, 20(4): 711-720. • Physician’s Desk Reference 2005, 59th ed.: 907-908. • Drug Information Handbook 2005, 13th ed: 165-166. • RxList The Internet Drug Index on the web at http://www.rxlist.com/cgi/pharmclips.cgi?keyword=AZELEX (last accessed Nov. 28, 2005). • Nazzaro-Porro, M., Passai, S., Picardo, M., Breathnach, A., Clayton, R. Zina, G., Beneficial effect of 15% azelaic acid cream on acne vulgaris. British Journal of Dermatology (1983) 109:45-48 • Cavicchini, S., Caputo, R. Long-term Treatment of Acne with 20% Azelaic Acid Cream. Acta Dermato-Venereologica (1989) Suppliment 143:40-44 • Hjorth, N., Graupe, K. Azelaic Acid for the Treatment of Acne: A Clinical comparison with Oral Tetracycline. Acta Derm Venereologica (1989) Suppliment 143:45-48 • Spellmajn, M.C., Pincus, S. H. Efficacy and Safety of Azelaic Acid and Glycolic Acid Combination Therapy Compared with Tretinoin Therapy for Acne. Clinical Therapeutics (1998) 20:4 711-720 • Gollinick, H. P. M., Graupe, K., Zaumseil. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. European Journal Dermatology (2001) 11:538-44. • Gass, S. Expert opinion of a practicing dermatologist.

More Related